$SURF Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Surface Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Surface Oncology, Inc.. Get notifications about new insider transactions in Surface Oncology, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2018 | SURF | Surface Oncology, ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BASKETT FOREST | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRIS PETER J | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 5,214,286 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 1,571,429 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | P | 15.00 | 766,666 | 11,499,990 | 3,948,482 | 3.2 M to 3.9 M (+24.10 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 909,090 | 0 | 3,181,816 | 2.3 M to 3.2 M (+40.00 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 2,272,726 | 0 | 2,272,726 | 0 to 2.3 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 5,214,286 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Option Exercise | C | 0.00 | 1,571,429 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | P | 15.00 | 766,666 | 11,499,990 | 3,948,482 | 3.2 M to 3.9 M (+24.10 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 909,090 | 0 | 3,181,816 | 2.3 M to 3.2 M (+40.00 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Novartis Institutes for BioMed ... | 10% Owner | Buy | C | 0.00 | 2,272,726 | 0 | 2,272,726 | 0 to 2.3 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Atlas Venture Fund IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Atlas Venture Fund IX, L.P. | 10% Owner | Buy | P | 15.00 | 100,000 | 1,500,000 | 4,645,453 | 4.5 M to 4.6 M (+2.20 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Atlas Venture Fund IX, L.P. | 10% Owner | Buy | C | 0.00 | 3,181,817 | 0 | 4,545,453 | 1.4 M to 4.5 M (+233.33 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Buy | P | 15.00 | 100,000 | 1,500,000 | 4,645,453 | 4.5 M to 4.6 M (+2.20 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | GRAYZEL DAVID S. | Director | Buy | C | 0.00 | 3,181,817 | 0 | 4,545,453 | 1.4 M to 4.5 M (+233.33 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | LV Management Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | LV Management Group, LLC | 10% Owner | Buy | P | 15.00 | 266,000 | 3,990,000 | 3,447,817 | 3.2 M to 3.4 M (+8.36 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | LV Management Group, LLC | 10% Owner | Buy | C | 0.00 | 3,181,817 | 0 | 3,181,817 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Buy | P | 15.00 | 266,000 | 3,990,000 | 3,447,817 | 3.2 M to 3.4 M (+8.36 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Buy | C | 0.00 | 3,181,817 | 0 | 3,181,817 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Sigal Charles Elliott | Director | Buy | C | 0.00 | 45,453 | 0 | 45,453 | 0 to 45.5 K |